Skip to content

Clinical trials

Completed Phase 3 Peripheral Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Nervous System Diseases Phase: Phase 3 Status: Completed Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20034
20054
20063
20074
20081
20091
20112
20141
20152
20161
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NeurogesX5
Jazz Pharmaceuticals4
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Alliance for Clinical Trials in Oncology1
Aya Mohamed Sadek Elsaid1
Baxalta now part of Shire1
Eastern Virginia Medical School1
Eli Lilly and Company1
Gary Morrow1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Nervous System Diseases28
Pain15
Diabetic Neuropathies6
Neuralgia5
Diabetes Mellitus4
HIV Infections4
Neurotoxicity Syndromes4
Herpes Zoster3
Polyneuropathies3
Neuralgia, Postherpetic2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.